Cargando…
Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC
INTRODUCTION: Systemic treatment with chemotherapy is warranted for patients with extensive-stage SCLC (ES-SCLC). The objective of this study was to determine whether racial and other healthcare disparities exist in receipt of chemotherapy for ES-SCLC. METHODS: Utilizing the National Cancer Database...
Autores principales: | Tapan, Umit, Furtado, Vanessa Fiorini, Qureshi, Muhammad Mustafa, Everett, Peter, Suzuki, Kei, Mak, Kimberley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474393/ https://www.ncbi.nlm.nih.gov/pubmed/34589974 http://dx.doi.org/10.1016/j.jtocrr.2020.100109 |
Ejemplares similares
-
Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival
por: Lee, Michelle H., et al.
Publicado: (2022) -
Durvalumab: A Review in Extensive-Stage SCLC
por: Al-Salama, Zaina T.
Publicado: (2021) -
Correction to: Durvalumab: A Review in Extensive-Stage SCLC
por: Al-Salama, Zaina T.
Publicado: (2021) -
RACIAL-ETHNIC DISPARITIES IN HEALTHCARE SATISFACTION
por: Mueller, Collin, et al.
Publicado: (2019) -
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)
por: Oronsky, Bryan, et al.
Publicado: (2022)